Brigitte Schlegelberger

Brigitte Schlegelberger's AcademicInfluence.com Rankings

Philosophy

#8173

World Rank

#11502

Historical Rank

Logic

#5203

World Rank

#6584

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Brigitte Schlegelberger's Degrees

PhD Medicine University of Cologne

Why Is Brigitte Schlegelberger Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Brigitte Schlegelberger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. (2008) (1608)
Oncogene-induced senescence as an initial barrier in lymphoma development (2005) (1182)
A physical map of the human genome (2001) (753)
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease (2010) (732)
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. (2012) (539)
Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity (2014) (443)
TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression. (2011) (442)
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q. (2011) (413)
RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group. (2011) (406)
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32) (1999) (400)
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. (2011) (389)
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. (2012) (388)
Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group. (2011) (364)
Clonal Dominance of Hematopoietic Stem Cells Triggered by Retroviral Gene Marking (2005) (340)
MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). (1997) (338)
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia. (2011) (315)
The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. (2001) (308)
Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. (2011) (282)
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo. (2014) (277)
Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. (2016) (274)
The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2. (2005) (271)
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes. (2011) (270)
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. (2011) (262)
Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor. (2010) (247)
Persistent malignant stem cells in del(5q) myelodysplasia in remission. (2010) (245)
High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. (2010) (243)
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. (2002) (243)
High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. (2006) (241)
All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. (1997) (232)
Breast cancer susceptibility: current knowledge and implications for genetic counselling (2009) (225)
Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. (2010) (210)
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV. (2010) (208)
Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis. (2005) (205)
Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31 (2004) (202)
Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. (2004) (200)
Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. (2006) (193)
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features (2016) (193)
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants (2017) (189)
Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group. (2009) (188)
Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma (2003) (187)
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. (2010) (187)
IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis (2010) (186)
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML. (2018) (184)
Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients (2001) (184)
Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies. (2003) (183)
Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. (2012) (179)
Childhood cancer predisposition syndromes—A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology (2017) (172)
Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia. (2005) (164)
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG). (2013) (164)
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia. (2013) (162)
Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications. (2014) (159)
Breast carcinoma during pregnancy (2006) (159)
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG). (2013) (156)
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies. (2012) (151)
Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. (1995) (150)
Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. (2000) (150)
Exonuclease-1 Deletion Impairs DNA Damage Signaling and Prolongs Lifespan of Telomere-Dysfunctional Mice (2007) (147)
Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. (1992) (147)
Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. (1996) (147)
MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. (2007) (144)
Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. (2001) (139)
Disease evolution and outcomes in familial AML with germline CEBPA mutations. (2015) (137)
MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis. (1998) (131)
Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p23.1. (1997) (130)
MicroRNA miR‐335 is crucial for the BRCA1 regulatory cascade in breast cancer development (2011) (129)
Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. (2013) (127)
Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia. (2010) (123)
Next‐generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3‐ITD or NPM1 mutations (2012) (116)
Classical and Molecular Cytogenetics of Tumor Cells (1999) (112)
Parthenogenetic stem cells for tissue-engineered heart repair. (2013) (109)
CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation. (2005) (107)
TEGDMA Causes Apoptosis in Primary Human Gingival Fibroblasts (2003) (105)
Radiation Rescue: Mesenchymal Stromal Cells Protect from Lethal Irradiation (2011) (105)
The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4. (2017) (102)
Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression (2009) (102)
Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes (2008) (101)
Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci (2002) (101)
Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. (2005) (100)
Molecular analysis of single B cells from T-cell-rich B-cell lymphoma shows the derivation of the tumor cells from mutating germinal center B cells and exemplifies means by which immunoglobulin genes are modified in germinal center B cells. (1999) (96)
Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. (2010) (96)
Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16 (2008) (95)
A 3‐cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization (2000) (95)
Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients (2000) (94)
The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo. (2007) (92)
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS. (2007) (91)
Effects of BisGMA on glutathione metabolism and apoptosis in human gingival fibroblasts in vitro. (2004) (91)
Clinicopathologic correlations of genomic gains and losses in follicular lymphoma. (2002) (91)
Refined histopathologic scoring system improves power todetect colitis QTL in mice (2004) (88)
Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium (2013) (88)
Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia. (2005) (87)
SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications (2012) (87)
Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group. (2013) (85)
Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11 (2007) (84)
Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor. (2013) (83)
Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population (2005) (83)
Gene therapy for Wiskott-Aldrich syndrome-long - Term efficacy and genotoxicity (Science Translational Medicine) (2014) (82)
Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup. (2009) (81)
Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study Group. (1999) (80)
Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation. (2017) (80)
Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression (2010) (80)
Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation. (1996) (78)
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial (2018) (78)
Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review (2007) (77)
Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7 (2017) (75)
Assignment1 of human putative tumor suppressor genes ST13 (alias SNC6) and ST14 (alias SNC19) to human chromosome bands 22q13 and 11q24→q25 by in situ hybridization (1999) (75)
Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions (2008) (75)
Telomere shortening and chromosomal instability in myelodysplastic syndromes (2009) (75)
The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis (1997) (74)
Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany (2011) (74)
A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2 (2012) (71)
Distinct Methylation Patterns of Benign and Malignant Liver Tumors Revealed by Quantitative Methylation Profiling (2005) (70)
The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (AML M4Eo) and carry the pericentric inversion 16: a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization. (1996) (70)
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history (2018) (67)
Frequent deletions of 6q23–24 in B‐cell non‐Hodgkin's lymphomas detected by fluorescence in situ hybridization (1997) (67)
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial. (2005) (67)
Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma. (2004) (67)
Detection of aberrant clones in nearly all cases of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined interphase and metaphase cytogenetics. (1994) (67)
Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma (2005) (66)
Which compartments are involved in Philadelphia‐chromosome positive chronic myeloid leukaemia? An answer at the single cell level by combining May‐Grünwald‐Giemsa staining and fluorescence in situ hybridization techniques (1997) (66)
Tumor cells escape suicide gene therapy by genetic and epigenetic instability. (2004) (66)
Application of interphase fluorescence in situ Hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas. (1998) (65)
Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci (2003) (64)
RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM). (2017) (62)
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML (2015) (61)
Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome. (2016) (61)
Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia (2007) (61)
Rapid immunophenotypic characterization of chromosomally aberrant cells by the new FICTION method. (1993) (60)
Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML. (2012) (60)
Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation (2014) (59)
Loss of heterozygosity on chromosome 6q14–q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma (2006) (58)
Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells (2013) (58)
Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia. (2012) (58)
Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type. (1996) (57)
AIMP3 haploinsufficiency disrupts oncogene-induced p53 activation and genomic stability. (2006) (57)
Aberrant microRNA expression pattern in myelodysplastic bone marrow cells. (2010) (57)
Cytogenetic findings and results of combined immunophenotyping and karyotyping in Hodgkin's disease. (1994) (56)
Hypermethylation of the suppressor of cytokine signalling‐1 (SOCS‐1) in myelodysplastic syndrome (2005) (55)
Constitutional mismatch repair deficiency and childhood leukemia/lymphoma – report on a novel biallelic MSH6 mutation (2010) (55)
Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas. (1998) (55)
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study (2016) (54)
Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-. (2012) (54)
CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo (2017) (54)
Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1 (2010) (54)
Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas (1994) (54)
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks (2006) (53)
Stepwise development of chromosomal abnormalities in angioimmunoblastic lymphadenopathy. (1990) (53)
Complex variant translocation t(1;2) with TPM3-ALK fusion due to cryptic ALK gene rearrangement in anaplastic large-cell lymphoma. (1999) (52)
Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses. (2006) (52)
Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fcγ receptor II (CD32) (2007) (51)
Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia. (2011) (51)
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants (2020) (51)
High-affinity neurotrophin receptors and ligands promote leukemogenesis. (2009) (51)
Combined immunophenotyping and interphase cytogenetics on cryostat sections by the new FICTION method. (1993) (51)
Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization (2001) (50)
Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization. (2006) (50)
Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance (2013) (50)
Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome. (2010) (49)
Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas. (1994) (49)
FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotype (2011) (48)
Monitoring CSF Proteome Alterations in Amyotrophic Lateral Sclerosis: Obstacles and Perspectives in Translating a Novel Marker Panel to the Clinic (2012) (48)
Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management (2012) (48)
Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519. (2004) (47)
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia (2018) (46)
The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells. (2010) (46)
Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia (2013) (46)
Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation (2017) (45)
The BCL 11 gene family : involvement of BCL 11 A in lymphoid malignancies (2001) (45)
On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer (2016) (44)
Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis (2017) (43)
Report of the European Task Force on Lymphomas: workshop on peripheral T-cell lymphomas. (1998) (43)
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes (2021) (43)
Recurrent chromosome abnormalities in peripheral T-cell lymphomas. (1994) (42)
Identification of candidate tumor‐suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms (2003) (42)
Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis (2017) (41)
Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma (2004) (41)
The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants (2019) (40)
Acute Myeloid Leukemia with Translocation (8;21). Cytomorphology, Dysplasia and Prognostic Factors in 41 Cases (1996) (40)
All-Trans Retinoic Acid Improves Outcome in Younger Adult Patients with Nucleophosmin-1 Mutated Acute Myeloid Leukemia – Results of the AMLSG 07-04 Randomized Treatment Trial (2011) (39)
Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, FISH and FICTION studies (1996) (39)
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper (2020) (39)
Acute myeloid leukemia with translocation (8;21). Cytomorphology, dysplasia and prognostic factors in 41 cases. AML Cooperative Group and ECOG. (1996) (39)
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis (2018) (39)
Analysis of NUP98/NSD1 translocations in adult AML and MDS patients (2013) (39)
A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation? (2009) (39)
Erratum: Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-q23.1 in lymphoproliferative disorders (Proceedings of the National Academy of Sciences of the United States of America (October 15, 1996) 93:21 (11837-11841)) (1996) (38)
Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome. (2007) (38)
Translocation t(2;5) is not a primary event in Hodgkin's disease. Simultaneous immunophenotyping and interphase cytogenetics. (1996) (37)
Concise Review: Managing Genotoxicity in the Therapeutic Modification of Stem Cells (2011) (37)
Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma (2008) (37)
Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, ΔTrkA (2007) (37)
BCR-ABL gene amplification and overexpression in a patient with chronic myeloid leukemia treated with imatinib. (2005) (36)
Global increase in DNA methylation in patients with myelodysplastic syndrome (2008) (36)
Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas. (2007) (35)
Prognostic implications and molecular associations of NADH dehydrogenase subunit 4 (ND4) mutations in acute myeloid leukemia (2012) (34)
Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes (2012) (34)
Standardised fluorescence in situ hybridisation in cytological and histological specimens (2005) (34)
Lenalidomide in the context of complex karyotype or interrupted treatment: case reviews of del(5q)MDS patients with unexpected responses (2006) (34)
Deregulation of the endogenous C/EBPβ LIP isoform predisposes to tumorigenesis (2014) (33)
Epigenetic inactivation of tumour suppressor gene KLF11 in myelodysplastic syndromes * (2010) (32)
Genetic instability of modified stem cells - a first step towards malignant transformation? (2013) (32)
Randomized Comparison of Imatinib 800 Mg Vs. Imatinib 400 Mg +/- IFN in Newly Diagnosed BCR/ABL Positive Chronic Phase CML: Analysis of Molecular Remission at 12 Months; The German CML-Study IV. (2009) (32)
Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancer (2014) (32)
IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas. (2018) (32)
Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group (2016) (32)
Simultaneous presence of t(11;14) and a variant Burkitt's translocation in the terminal phase of a mantle cell lymphoma. (1996) (32)
MDS1 and EVI1 complex locus (MECOM): a novel candidate gene for hereditary hematological malignancies (2017) (31)
The CpG island methylator phenotype in breast cancer is associated with the lobular subtype. (2015) (31)
Chromosomal aberrations in congenital bone marrow failure disorders—an early indicator for leukemogenesis? (2007) (31)
Comprehensive genetic and functional characterization of IPH‐926: a novel CDH1‐null tumour cell line from human lobular breast cancer (2009) (31)
Breast carcinoma during pregnancy. International recommendations from an expert meeting. (2006) (31)
Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16) (2004) (30)
Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study (2014) (29)
Germline variants drive myelodysplastic syndrome in young adults (2021) (29)
Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia‐associated myeloproliferative neoplasms (2015) (29)
RBC Transfusion Independence and Safety Profile of Lenalidomide 5 or 10 mg in Pts with Low- or Int-1-Risk MDS with Del5q: Results From a Randomized Phase III Trial (MDS-004). (2009) (29)
Cell lineage specific involvement in acute promyelocytic leukaemia (APL) using a combination of May‐Grünwald‐Giemsa staining and fluorescence in situ hybridization techniques for the detection of the translocation t(15;17)(q22;q12) (1998) (28)
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols (2019) (28)
A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic type. (2012) (28)
New insights into the biology of Philadelphia‐chromosome‐positive acute lymphoblastic leukaemia using a combination of May‐Grünwald‐Giemsa staining and fluorescence in situ hybridization techniques at the single cell level (1997) (28)
Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM 1 to JAK 2 (2005) (28)
Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas (2006) (27)
TET2 mutations in cytogenetically normal acute myeloid leukemia: Clinical implications and evolutionary patterns (2014) (27)
Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials. (2007) (27)
Deletions in the Long Arm of Chromosome 10 in Lymphomas With t(14;18): A Pathogenetic Role of the Tumor Suppressor Genes PTEN/MMAC1 and MXI1? (1998) (27)
Update on cytogenetic and molecular changes in myelodysplastic syndromes (2012) (26)
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features (2016) (26)
Cytogenetical assignment and physical mapping of the human R-PTP-kappa gene (PTPRK) to the putative tumor suppressor gene region 6q22.2-q22.3. (1998) (26)
No evidence for deletions of the NBS1 gene in lymphomas. (2001) (26)
Detection of chromosome 11 alterations in blood and bone marrow by interphase cytogenetics in mantle cell lymphoma (1995) (26)
Cancer Genetics Service Provision: A Comparison of Seven European Centres (2004) (26)
High-risk additional chromosomal abnormalities at low blast counts herald death by CML (2020) (25)
Treatment of myelodysplastic syndrome with isolated del(5q) including bands q31–q33 with a combination of all-trans-retinoic acid and tocopherol-α: a phase II study (2005) (25)
Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease (2008) (25)
Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide (2012) (25)
CDKN2A loss and PIK3CA mutation in myoepithelial‐like metaplastic breast cancer (2018) (25)
Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics. (1998) (24)
Hyperactivation of mTORC1 and mTORC2 by multiple oncogenic events causes addiction to eIF4E-dependent mRNA translation in T-cell leukemia (2014) (24)
Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13-driven mouse model. (2011) (24)
HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma (2016) (24)
[Counselling, genetic testing and prevention in women with hereditary breast- and ovarian cancer. Interdisciplinary recommendations of the consortium "Hereditary Breast- and Ovarian Cancer" of the German Cancer AiD]. (2003) (24)
Malignant histiocytosis and large cell anaplastic (Ki-1) lymphoma in childhood: guidelines for differential diagnosis--report of the Histiocyte Society. (1994) (24)
MicroRNA miR-548d Is a Superior Regulator in Pancreatic Cancer (2012) (23)
Anti-Angiogenic In Vivo Effect of Lenalidomide (CC-5013) in Myelodysplastic Syndrome with del(5q) Chromosome Abnormality and Its Relation to the Course of Disease. (2005) (23)
Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase (2014) (23)
Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma (2019) (23)
Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance (2020) (23)
Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype (2014) (23)
The differentiation/retrodifferentiation program of human U937 leukemia cells is accompanied by changes of VCP/p97 (2008) (22)
A child with Li–Fraumeni syndrome: Modes to inactivate the second allele of TP53 in three different malignancies (2015) (22)
Chromosome aberrations are restricted to the CD56+, CD3− tumour cell population in natural killer cell lymphomas: a combined immunophenotyping and FISH study (1999) (22)
Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome (2007) (22)
Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia (2011) (22)
Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q (2015) (22)
Classification of peripheral T-cell lymphomas: cytogenetic findings support the updated Kiel classification. (1996) (21)
A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignancies (2012) (21)
Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide (2011) (21)
Constitutional trisomy 8p11.21‐q11.21 mosaicism: a germline alteration predisposing to myeloid leukaemia (2011) (21)
An immortalized cell line with features of human follicular dendritic cells. Antigen and cytokine expression analysis (1994) (21)
Angioimmunoblastic lymphadenopathy with trisomy 3: the cells of the malignant clone are T cells. (1990) (21)
Nf1 haploinsufficiency and Icsbp deficiency synergize in the development of leukemias. (2009) (21)
Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance (2006) (21)
Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). (2008) (20)
Histopathological criteria and selection algorithms for BRCA1 genetic testing. (2009) (20)
Diagnosis of monogenic liver diseases in childhood by next‐generation sequencing (2018) (20)
Shared Copy Number Variation in Simultaneous Nephroblastoma and Neuroblastoma due to Fanconi Anemia (2012) (20)
IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis (2020) (20)
Response-Adapted Sequential Immuno-Chemotherapy of Post-Transplant Lymphoproliferative Disorders in Pediatric Solid Organ Transplant Recipients: Results from the Prospective Ped-PTLD 2005 Trial (2014) (19)
Comparison of different methods for telomere length measurement in whole blood and blood cell subsets: Recommendations for telomere length measurement in hematological diseases (2017) (19)
Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid‐papillary carcinoma (2017) (19)
Discrimination of distinct subpopulations within a tumor with combined double immunophenotyping and interphase cytogenetics. (1993) (19)
Detection of secondary genetic aberrations in follicle center cell derived lymphomas: assessment of the reliability of comparative genomic hybridization and standard chromosome analysis (2001) (19)
FLA‐IDA salvage chemotherapy combined with a seven‐day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia (2020) (19)
The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia (2021) (19)
Assignment1 of human proliferation associated p100 gene (C20orf1) to human chromosome band 20q11.2 by in situ hybridization (1999) (19)
High-dose chemotherapy and autologous bone marrow transplantation in relapsing angioimmunoblastic lymphadenopathy with dysproteinemia (AILD). (1991) (18)
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV (2018) (18)
Serum‐ and Stromal Cell‐Free Hypoxic Generation of Embryonic Stem Cell‐Derived Hematopoietic Cells In Vitro, Capable of Multilineage Repopulation of Immunocompetent Mice (2012) (18)
Gene correction of HAX1 reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cells. (2017) (18)
Neurogenic transdifferentiation of human adipose-derived stem cells? A critical protocol reevaluation with special emphasis on cell proliferation and cell cycle alterations (2010) (18)
Progression of myeloproliferative neoplasms to myelofibrosis and acute leukaemia (2011) (18)
MDR-1-overexpression in HT 29 colon cancer cells grown in SCID mice. (2012) (18)
Identification of genetic imbalances in malignant lymphoma using comparative genomic hybridization (1995) (18)
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations. (2019) (18)
Cyclin D 3 is a target gene of t ( 6 ; 14 ) ( p 21 . 1 ; q 32 . 3 ) of mature B-cell malignancies (2001) (17)
Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy (2015) (17)
Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease (1995) (17)
Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia (2001) (17)
Recurrent trisomy and Robertsonian translocation of chromosome 14 in murine iPS cell lines (2011) (17)
Identification of disease- and therapy-associated proteome changes in the sera of patients with myelodysplastic syndromes and del(5q) (2010) (17)
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia (2020) (17)
Clarification of dubious karyotypes in Hodgkin's disease by simultaneous fluorescence immunophenotyping and interphase cytogenetics (FICTION). (1995) (16)
Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) - update 2012 (2012) (16)
Cytogenetics and molecular cytogenetics in Hodgkin's disease. (1996) (16)
Knockout of the HMG domain of the porcine SRY gene causes sex reversal in gene-edited pigs (2020) (16)
Common fragile sites in couples with recurrent spontaneous abortions. (1989) (15)
Preferential loss of porcine chromosomes in reprogrammed interspecies cell hybrids. (2010) (15)
SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3 (2012) (15)
Detection of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization (1998) (15)
Stable and reproducible engraftment of primary adult and pediatric acute myeloid leukemia in NSG mice (2011) (15)
Clonal heterogeneity in childhood myelodysplastic syndromes—Challenge for the detection of chromosomal imbalances by array‐CGH (2010) (15)
Cytogenetic and molecular characterization of a patient with simultaneous B‐cell chronic lymphocytic leukemia and peripheral T‐cell lymphoma (2001) (14)
Feasibility of simultaneous fluorescence immunophenotyping and fluorescence in situ hybridization study for the detection of estrogen receptor expression and deletions of the estrogen receptor gene in breast carcinoma cell lines (2000) (14)
Amplification of ERBB2, RARA, and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia. (2001) (14)
Telomere shortening, TP53 mutations and deletions in chronic lymphocytic leukemia result in increased chromosomal instability and breakpoint clustering in heterochromatic regions (2016) (14)
Induction of Chromosomal Instability via Telomere Dysfunction and Epigenetic Alterations in Myeloid Neoplasia (2013) (14)
Rare compound heterozygous variants in PNKP identified by whole exome sequencing in a German patient with ataxia‐oculomotor apraxia 4 and pilocytic astrocytoma (2018) (14)
Unexpected High Frequency of GATA2 Mutations in Children with Non-Familial MDS and Monosomy 7 (2012) (14)
Managing individuals with propensity to myeloid malignancies due to germline RUNX1 deficiency (2011) (14)
Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML (2010) (14)
Variant Philadelphia translocation t(9;17)(q34.2-3;q21.3) with colocalization of the BCR and ABL genes on chromosome 9 in chronic myeloid leukemia. (1997) (13)
Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2) (2010) (13)
Somatic Genetic and Epigenetic Architecture of Myelodysplastic Syndromes Arising from GATA2 Deficiency (2015) (13)
Bronchoalveolar lavage fluid of lung cancer patients: mapping the uncharted waters using proteomics technology. (2011) (13)
Proteomic Bronchiolitis Obliterans Syndrome Risk Monitoring in Lung Transplant Recipients (2011) (13)
Expression of the p75 neurotrophin receptor in acute leukaemia (2005) (13)
Losses of Chromosome Arms 4q, 8p, 13q and Gain of 8q Are Correlated with Increasing Chromosomal Instability in Hepatocellular Carcinoma (2008) (13)
Chromosomal mapping of the genes GPRK5 and GPRK6 encoding G protein-coupled receptor kinases GRK5 and GRK6. (1995) (13)
In memoriam: Prof. Dr. rer. nat. Dr. med. h.c. Lore Zech; 24.9.1923 – 13.3.2013: Honorary member of the European Society of Human Genetics, Honorary member of the German Society of Human Genetics, Doctor laureate, the University of Kiel, Germany (2013) (13)
Spectral karyotyping and fluorescence in situ hybridization of murine cells. (2009) (12)
Jumping translocation of 1q as the sole aberration in a case of follicular lymphoma. (1999) (12)
Randomized Comparison of Imatinib 400 Mg Vs. Imatinib + IFN Vs. Imatinib + AraC Vs. Imatinib after IFN Vs. Imatinib 800 Mg: Optimized Treatment and Survival. Designed First Interim Analysis of the German CML Study IV (2008) (12)
A tandem duplication of BRCA1 exons 1–19 through DHX8 exon 2 in four families with hereditary breast and ovarian cancer syndrome (2018) (12)
The heteromeric transcription factor GABP activates the ITGAM/CD11b promoter and induces myeloid differentiation. (2015) (12)
Combined immunophenotyping and karyotyping in peripheral T cell lymphomas demonstrating different clonal and nonclonal chromosome aberrations in T helper cells. (1994) (12)
[Methylation status of LINE-1 sequences in patients with MDS or secondary AML]. (2007) (11)
Detection of translocations involving the HOX11/TCL3-locus in 10q24 by interphase fluorescence in situ hybridization. (2001) (11)
THE ROLE OF THE SPLEEN AFTER BONE MARROW TRANSPLANTATION FOR PRIMARY MYELOFIBROSIS (1992) (11)
Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia. (2014) (11)
Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin. (2008) (11)
Chromosomal evolution in a Merkel cell carcinoma. (1994) (11)
Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia (2009) (11)
Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo (1993) (11)
Analysis of Array-CGH Data Using the R and Bioconductor Software Suite (2009) (10)
Communicating BRCA1 and BRCA2 genetic test results. (2006) (10)
Lymphohaematopoietic chimaerism after bone marrow transplantation for chronic myeloid leukaemia: results of simultaneous cytogenetic analyses on T‐cell colonies, myeloid, and erythroid progenitor cells (1991) (10)
Rationalization of in situ hybridization: testing up to 16 different probes on a single slide. (1993) (10)
Histone methyltransferase Suv39h1 deficiency prevents Myc‐induced chromosomal instability in murine myeloid leukemias (2013) (10)
ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia (2011) (10)
Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms (2017) (10)
Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis (2016) (10)
Jacobsen Syndrome and Beckwith‐Wiedemann Syndrome Caused by a Parental Pericentric Inversion inv(11)(p15q24) (2006) (10)
Loss of Dnd1 facilitates the cultivation of genital ridge-derived rat embryonic germ cells. (2011) (10)
[Azathioprine-associated myelodysplastic syndrome with cytogenetic aberrations]. (2004) (9)
Mesenteric chloroma with t(16;16) followed by acute myelomonocytic leukemia with clonal evolution. (2007) (9)
Identification and characterization of a novel human brain-specific gene, homologous to S. scrofa tmp83.5, in the chromosome 10q24 critical region for temporal lobe epilepsy and spastic paraplegia. (2002) (9)
t(2;3)(p12;q27) in Hodgkin's disease of a human immunodeficiency virus-positive patient with hemophilia. (1993) (9)
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Imatinib-Era: Update on the Survival Outcome Following Allogeneic HSCT after Imatinib Failure; Results of the German CML Study IV (2008) (9)
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity (2018) (9)
Bortezomib Treatment can Overcome Glucocorticoid Resistance in Childhood B-cell Precursor Acute Lymphoblastic Leukemia Cell Lines (2015) (9)
Guiding the global evolution of cytogenetic testing for hematologic malignancies (2022) (9)
Recurrent involvement of heterochromatic regions in multiple myeloma-a multicolor FISH study. (2010) (9)
Improved generation of patient-specific induced pluripotent stem cells using a chemically-defined and matrigel-based approach. (2013) (9)
Impaired formation of erythroblastic islands is associated with erythroid failure and poor prognosis in a significant proportion of patients with myelodysplastic syndromes (2016) (9)
No evidence for breast cancer susceptibility associated with variants of BRD7, a component of p53 and BRCA1 pathways (2012) (9)
Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany (2000) (9)
Detection of structural chromosome aberrations in immunophenotyped mitoses. (1992) (9)
GT198 (PSMC3IP) germline variants in early-onset breast cancer patients from hereditary breast and ovarian cancer families (2017) (8)
Long-Term Cytogenetic Follow-up of MDS Patients with 5q- Treated within the MDS-003 (CC-5013-MDS-003) Study: Evolution to Complex Clones and Progression to AML. (2008) (8)
Clinical Impact of WT1 Mutations in the Context of Other Molecular Markers in Cytogenetically Normal Acute Myeloid Leukemia (AML): A Study of the German-Austrian AML Study Group (AMLSG). (2007) (8)
The stem cell zinc finger 1 (SZF1)/ZNF589 protein has a human-specific evolutionary nucleotide DNA change and acts as a regulator of cell viability in the hematopoietic system. (2016) (8)
The German competence network ‘Acute and chronic leukemias’ (2004) (8)
Clinical utility gene card for: Familial platelet disorder with associated myeloid malignancies (2016) (8)
Comprehensive MALDI-TOF Biotyping of the Non-Redundant Harvard Pseudomonas aeruginosa PA14 Transposon Insertion Mutant Library (2015) (8)
Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP‐BFM acute lymphoblastic leukemia protocol (2020) (8)
Lack of deletions of the PTEN/MMAC1 and MXI1 loci in renal cell carcinoma by interphase cytogenetics. (2000) (7)
Efficacy of Gene Therapy for Wiskott-Aldrich-Syndrome (2011) (7)
Women’s Experiences of Undergoing BRCA1 and BRCA2 Testing: Organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster (2004) (7)
Preserved reticulin network in a case of hepatocellular carcinoma (2006) (7)
MTF1 binds to metal‐responsive element e within the ATP7B promoter and is a strong candidate in regulating the ATP7B expression (2020) (7)
Translocation (X;8)(q2?6;q21.3) in a case of systemic mastocytosis. (1994) (7)
Inv(14)(q11q32) in one of four different clones in a case of angioimmunoblastic lymphadenopathy. (1990) (7)
Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas (2013) (7)
Low frequency of calreticulin mutations in MDS patients (2014) (7)
Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies (2021) (7)
Mutations in the let-7 binding site - a mechanism of RAS activation in juvenile myelomonocytic leukemia? (2010) (7)
Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia (2014) (7)
Archival bone marrow trephines are suitable for high-throughput mutation analysis using next generation sequencing technology (2013) (7)
Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up (2020) (7)
Deletions in the long arm of chromosome 10 in lymphomas with t(14;18): a pathogenetic role of the tumor supressor genes PTEN/MMAC1 and MXI1? (1998) (7)
GABP is necessary for stem/progenitor cell maintenance and myeloid differentiation in human hematopoiesis and chronic myeloid leukemia. (2016) (6)
Fluorescence in situ hybridization using the subtelomeric 11q probe as a diagnostic tool for congenital thrombocytopenia (2006) (6)
The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer (2011) (6)
Cryptic t(15;17) in a patient with AML M3 and a complex karyotype. (2007) (6)
12q14 microdeletion syndrome: A family with short stature and Silver-Russell syndrome (SRS)-like phenotype and review of the literature. (2018) (6)
Molecular Predictors of Outcome in Patients with MDS and AML Following MDS after Allogeneic Hematopoietic Stem Cell Transplantation (2015) (6)
SELECTED PA PERS (2001) (6)
Frequent allelic loss of the BCL10 gene in lymphomas with the t(11;14)(q13;q32) (2001) (6)
MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in AML patients (2007) (6)
Human BRCA1-Associated Breast Cancer: No Increase in Numerical Chromosomal Instability Compared to Sporadic Tumors (2011) (6)
Bronchial epithelial cells as a new source for differential transcriptome analysis after lung transplantation. (2009) (6)
Probable autosomal recessive syndrome with triphalangia of thumbs, thrombasthenia Glanzmann and deafness of internal ear. (1986) (6)
Acute monocytic leukemia with translocation t(1;11) (p31;q23): simultaneous staining of chromosomes and cell surface antigens. (1990) (6)
Chromosomal Instability and Telomere Shortening in Long-Term Culture of Hematopoietic Stem Cells: Insights from a Cell Culture Model of RPS14 Haploinsufficiency (2013) (6)
Anti-Angiogenic in-Vivo Effect of Lenalidomide and Its Impact On Neoplastic and Non-Neoplastic Hematopoiesis in MDS with Del(5q) Chromosome Abnormality. (2009) (6)
Looking for the hidden mutation: Bannayan–Riley–Ruvalcaba syndrome caused by constitutional and mosaic 10q23 microdeletions involving PTEN and BMPR1A (2019) (6)
The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia (2017) (6)
Type and Number of Secondary Molecular Lesions Improve Outcome Prediction in Acute Myeloid Leukemia (AML) with inv(16) or t(16;16): A Study of the German-Austrian AML Study Group (AMLSG). (2009) (5)
Interphase cytogenetic characterization of aberrations in the long arm of chromosome 1 in B-cell lymphoid malignancies. (2003) (5)
Treatment and outcome of IG-MYC+ neoplasms with precursor B-cell phenotype in childhood and adolescence (2019) (5)
Cytogenetic characterization of a BCR-ABL transduced mouse cell line. (2005) (5)
κ‐ and λ‐positive cells in centroblastic‐centrocytic lymphoma (follicular lymphoma) may share a secondary chromosome aberration: Reflections on early lymphoma development (1995) (5)
Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion (2018) (5)
SSBP2-CSF1R is a Recurrent Fusion in B-lineage Acute Lymphoblastic Leukaemia with Diverse Genetic Presentation and Variable Outcome. (2020) (5)
Clonal t(8;14)(p11;q31) in a case of reactive lymphoproliferation (1993) (5)
Homozygous frame shift variant in ATP7B exon 1 leads to bypass of nonsense-mediated mRNA decay and to a protein capable of copper export (2019) (5)
Optimaization of Imatinib Therapy by Combination. 5 Year Survival and Response Results of the Pilot Phase of the Randomized German CML STUDY IV. (2009) (5)
Cytogenetic and molecular study of the PRDX4 gene in a t(X;18)(p22;q23): a cautionary tale. (2007) (5)
Appearance of a transient inv(14)(q11q32) in a case of B cell chronic lymphocytic leukemia. (1989) (5)
Exonuclease-1 Deletion Impairs DNA Damage Signaling and Prolongs Lifespan of Telomere-Dysfunctional Mice (2007) (5)
Phosphoinositide phospholipase Cbeta1 (PI-PLCbeta1) gene in myelodysplastic syndromes and cytogenetically normal acute myeloid leukemia: not a deletion, but increased PI-PLCbeta1 expression is an independent prognostic factor. (2010) (5)
[Genetic predisposition to childhood cancer]. (2018) (5)
Expression of the ETS transcription factor GABPα is positively correlated to the BCR-ABL1/ABL1 ratio in CML patients and affects imatinib sensitivity in vitro. (2015) (5)
Prognostic Effect of Mutations in the Splicing Gene Machinery in 339 Patients with MDS or Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation (2012) (5)
Mutations in the Fms-Related Tyrosine Kinase 3 (FLT3) Gene Independently Predict Poor Outcome in Acute Myeloid Leukemia (AML) with t(8;21): A Study of the German-Austrian AML Study Group (AMLSG). (2009) (5)
First non-imported HTLV-1 positive adult T cell leukemia/lymphoma (ATLL) in Germany (1999) (5)
Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics (2021) (5)
Monitoring of Minimal Residual Disease (MRD) of DNMT3A Mutations (DNMT3Amut) in Acute Myeloid Leukemia (AML): A Study of the AML Study Group (AMLSG) (2015) (5)
Impact of the type of the BCR-ABL fusion transcript on the molecular response in pediatric patients with chronic myeloid leukemia (2010) (5)
Induced G1 phase arrest of fast-dividing cells improves the quality of genomic profiles generated by array-CGH. (2012) (5)
RUNX1 Mutations in Acute Myeloid Leukemia (AML): Correlation with Distinct Cytogenetic Subgroups and Clinical Outcome. Results of the AML Study Group (AMLSG) (2008) (4)
No evidence for ITSN1 loss in a patient with mental retardation and complex chromosomal rearrangements of 21q21-21q22. (2013) (4)
RUNX1 Mutations Are the Most Frequent Leukemia Associated Mutations in Congenital Neutropenia Patients (2012) (4)
Association of Unbalanced Translocation der(1;7) with Germline GATA2 Mutations. (2021) (4)
Generation and characterization of a novel hematopoietic progenitor cell line with DC differentiation potential (2012) (4)
Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies (2021) (4)
[Monozygotic twins with Klinefelter syndrome (concordant) and systemic lupus erythematodes (discordant)]. (1984) (4)
An identical chromosome abnormality: der(6)t(6;7)(q13;p13) in two patients with peripheral T-cell lymphoma. (1991) (4)
A common ancestral DNMT3A-mutated preleukemic clone giving rise to AML and MDS in an adolescent girl (2017) (4)
Rational therapy with vigabatrin and a ketogenic diet in a patient with GAD1 deficiency. (2020) (4)
Characterization of the novel, pediatric Hodgkin disease-derived cell line HKB-1. (1998) (4)
Association Of Cytogenetic Response (CyR) With RBC Transfusion-Independence (RBC-TI) and AML-Free Survival In Lenalidomide (LEN)-Treated Patients (Pts) With IPSS Low-/Int-1-Risk Myelodysplastic Syndromes (MDS) With Del(5q) (2013) (4)
Fluorescence in situ Hybridization Reveals Closely Correlated Results in Cytological and Histological Specimens of Hematological Neoplasias Compared to Conventional Cytogenetics (2007) (4)
Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile (2020) (4)
Impact of Molecular Genetics on Disease-Free Survival in Myelofibrosis Patients Following Allogeneic Stem Cell Transplantation (2015) (4)
Re: B-cell non-Hodgkin's lymphoma: evidence for the t(14;18) translocation in all hematopoietic cell lineages. (1997) (4)
Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive ALK tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis (1999) (4)
Gene therapy for chronic granulomatous disease: Current status of the German clinical study (2008) (4)
Assignment1 of the human FAN protein gene (NSMAF) to human chromosome region 8q12→q13 by in situ hybridization (1999) (3)
The knockout of the HMG domain of the porcine SRY gene causes sex reversal in gene-edited pigs (2019) (3)
Prognostic Impact of Mutant to Wild-Type Ratio and Insertion Site in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication (2012) (3)
Pharmacodynamic Analysis Of The Inhibitory Potency Of The Tyrosine Kinase Inhibitor Midostaurin In Combination With Intensive Chemotherapy Including Allogeneic Hematopoietic Stem Cell Transplantation Followed By Maintenance Therapy In FLT3-ITD Positive Acute Myeloid Leukemia In The Ongoing AMLSG 16- (2013) (3)
Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias (2011) (3)
MicroRNA‐192‐5p inhibits migration of triple negative breast cancer cells and directly regulates Rho GTPase activating protein 19 (2021) (3)
Jumping translocations: Short telomeres or pathogenic TP53 variants as underlying mechanism in acute myeloid leukemia and myelodysplastic syndrome? (2019) (3)
High-Risk Additional Chromosomal Abnormalities in CML Herald Death By Blast Crisis Already at Low Blast Levels (2019) (3)
From a variant of unknown significance to pathogenic: Reclassification of a large novel duplication in BRCA2 by high‐throughput sequencing (2019) (3)
Long-term results of the 'Prospective study of the diagnosis and treatment of myelodysplastic syndromes in childhood (EWOG-MDS98)' (2015) (3)
Validation and clinical application of transactivation assays for RUNX1 variant classification (2022) (3)
The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q) (2018) (3)
Different breakage-prone regions on chromosome 1 detected in t(11;14)-positive mantle cell lymphoma cell lines and multiple myeloma cell lines are associated with different tumor progession-related mechanisms (2006) (3)
Identification of Clinically Relevant Predictive MRD Checkpoints in AML Patients with NPM1 Mutations: A Study of the AML Study Group (AMLSG). (2009) (3)
De novo missense variants in the RAP1B gene identified in two patients with syndromic thrombocytopenia (2020) (3)
Simultaneous fluorescence immunophenotyping and FISH on tumor cells. (2002) (3)
Frequency and Prognostic Impact of NUP98/NSD1 Translocations in Adult AML and MDS Patients (2012) (3)
Gene correction of HAX 1 reversed Kostmann disease phenotype in patient-speci fi c induced pluripotent stem cells (2017) (3)
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants (2020) (2)
MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF (2022) (2)
Fluorescence In Situ Hybridization (FISH) Using a Subtelomeric 11q Probe as a New Diagnostic Tool for Congenital Thrombocytopenia Caused by Deletions in 11q. (2004) (2)
Incidence and Prognostic Impact of Cytogenetics in Combination with Molecular Aberrations in Patients with Systemic Mastocytosis (2016) (2)
Evolution of Blast Crisis (BC) in Chronic Myeloid Leukemia (CML) in the Imatinib-Era: A Rare Event with High Proportions of Low Risk Patients and of Early Bc; Need for Rapid Detection. Results of the German CML Study IV. (2009) (2)
High Interleukin 15 Expression Characterizes Childhood Acute Lymphoblastic Leukemia with Involvement of the Central Nervous System. (2006) (2)
Phase I/II Gene Therapy Study for Chronic Granulomatous Disease: Results, Lessons and Perspectives. (2007) (2)
Abstract #2538: Identification of microRNAs miR-203 and miR-335 forming a network of regulation in breast cancer development (2009) (2)
Genome-Wide Single Nucleotide Polymorphism Analysis in Juvenile Myelomonocytic Leukemia Uncovers Long-Range Uniparental Disomy Surrounding the NF1 Locus in Cases Associated with Type 1 Neurofibromatosis but Not in Cases with Mutant RAS or PTPN11 . (2006) (2)
Therapy with Imatinib In Elderly CML Patients (>65years): Results of the German CML-Study IV. (2010) (2)
Patients with Del(5q) MDS Who Fail to Achieve Erythroid or Cytogenetic Remission After Treatment with Lenalidomide Have An Increased Risk for Clonal Evolution and AML Progression. (2009) (2)
Recent advances in breast cancer (2010) (2)
FLT3-ITD and Age Are the Major Prognostic Factors In Relapsed AML with Normal Karyotype (2010) (2)
Cryptic TCF3 fusions in childhood leukemia - detection by RNA-sequencing. (2021) (2)
Cytomorphological results and dysplastic features as prognostic factors in 41 cases with acute myeloid leukemia (AML) and translocation (1994) (2)
Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML (2020) (2)
Prognostic Impact Of a Newly Defined Structurally Complex Karyotype In Patients With AML and MDS After Allogeneic Stem Cell Transplantation (2013) (2)
Paediatric Cancer Predisposition Documentation Tool – Standardized Reporting Form for Children and Adolescents With Suspected Cancer Predisposition Syndrome (2021) (2)
Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype (2014) (2)
Clonal Evolution at First Sight: A Combined Visualization of Diverse Diagnostic Methods Improves Understanding of Leukemic Progression (2021) (2)
Analysis of the ETS Family Member Genes ERG, ETS2, ETS1 and FLI1 in Acute Myeloid Leukemia (AML) Patients with Normal Cytogenetics: Expression Levels and Impact On Clinical Outcome. A Study of the AMLSG. (2009) (2)
Outcomes In RBC Transfusion-Dependent Patients (Pts) With Low-/Intermediate (Int)-1-Risk Myelodysplastic Syndromes (MDS) With Isolated Deletion 5q Treated With Lenalidomide (LEN): A Subset Analysis From The MDS-004 Study (2013) (2)
Unbalanced translocation der(5;17) resulting in a TP53 loss as recurrent aberration in myelodysplastic syndrome and acute myeloid leukemia with complex karyotype (2021) (2)
Establishing a murine xenograft-model for long-term analysis of factors inducing chromosomal instability in myelodysplastic syndrome: Pitfalls and successes. (2016) (2)
Evolution of severe (transfusion‐dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage‐associated failure of the eythropoietic niche (2022) (2)
[Psychological aspects of genetic counseling]. (1986) (2)
Impact of Balanced or Unbalanced Karyotype At Diagnosis On Prognosis of CML: Long-Term Observation From 1346 Patients of the Randomized CML Study IV (2012) (2)
Beyond Pathogenic RUNX1 Germline Variants: The Spectrum of Somatic Alterations in RUNX1-Familial Platelet Disorder with Predisposition to Hematologic Malignancies (2022) (2)
Secondary AML After a History of Myelodysplastic Syndrome Is An Independent Adverse Prognostic Factor for Achievement of Complete Remission, Relapse-Free and Overall Survival. An Analysis of 2,819 Adult Patients with Newly Diagnosed AML Enrolled On Seven AMLSG Treatment Trials. (2009) (2)
Prognostic Effect of ASXL1 Mutations in Patients with MDS and Secondary AML Following MDS After Allogeneic Hematopoietic Stem Cell Transplantation (2011) (2)
P-211 Splicing gene mutations in MDS and secondary AML: Clinical implications in the setting of allogeneic hematopoietic stem cell transplantation (2013) (2)
Classification of fluorescent R-Band metaphase chromosomes using a convolutional neural network is precise and fast in generating karyograms of hematologic neoplastic cells (2021) (2)
Cytogenetic characteristics of a murine in vitro model for the human anaplastic large cell lymphoma (ALCL) (2006) (2)
Ago-RIP Sequencing Identifies New MicroRNA-449a-5p Target Genes Increasing Sorafenib Efficacy in Hepatocellular Carcinoma (2022) (2)
Effect of TP53 contact and conformational mutations on cell survival and erythropoiesis of human hematopoietic stem cells in a long term culture model (2018) (2)
ASSESSMENT OF IMATINIB 400MG AS FIRST LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: 10-YEAR SURVIVAL RESULTS OF THE RANDOMIZED CML STUDY IV (2017) (2)
Mutation analysis of the HAX1 gene in childhood myelodysplastic syndrome (2009) (2)
Clinical Impact of TERT A1062T Mutations in Younger Patients with Acute Myeloblastic Leukemia (2012) (2)
Monosomy 7 As the Initial Hit Followed By Sequential Acquisition of SETBP1 and ASXL1 Driver Mutations in Childhood Myelodysplastic Syndromes (2018) (2)
Clinical Relevance of Minimal Residual Disease Monitoring in NPM1 Mutated AML: A Study of the AML Study Group (AMLSG) (2015) (2)
Inv(14) with distal breakpoint in 14q32.1 in three cases of T cell lymphoma (1990) (2)
Routinely Prepared Cells for Cytogenetic Analysis Stored at −20 °C for Several Years can be Used for RT-PCR-Based Detection of Chromosomal Aberrations in Leukemias (1998) (2)
Macrophage Migration Inhibitory Factor (MIF) Promotes the Development of Murine Chronic Lymphocytic Leukemia (CLL) (2008) (1)
Gene therapy as a possible option to treat hereditary hearing loss (2020) (1)
The Prognostic Impact of Trisomy 8 in Acute Myeloid Leukemia: Do Accompanying Aberrations Influence Prognosis? (1998) (1)
The Impact of Therapy-Related and Secondary AML in Relation to Karyotype and Molecular Markers: A Study of the AMLSG. (2007) (1)
Simultaneous Fluorescence Immunophenotyping and FISH (FICTION) (2002) (1)
Prognosis of Low- or Intermediate-1-Risk MDS with Del(5q) Chromosome Abnormality During Lenalidomide Therapy Depends on the Capacity of the Neoplastic Stem Cell to Differentiate Into Maturing Erythroid Committed Stem Cells, (2011) (1)
Hereditary breast and ovarian cancer (2007) (1)
Hypermethylation of cyclin D2 and DAP kinase is associated with the lobular subtype of breast cancer (2005) (1)
Prognostic Impact of Splicing Factor Mutations in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (2014) (1)
Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker (2022) (1)
Phyllis Jean McAlpine, Ph.D, FCCMG (1999) (1)
Proteasome inhibitor bortezomib induces apoptosis in prednisone-resistant childhood acute lymphoblastic leukemia cells (2010) (1)
In CML, Marrow Fibrosis Relapses or Emerges in 5 - 6 % of Patients Per Year Independently Indicating Imatinib Failure and Shortened Survival Time of Patients. (2006) (1)
Measurable residual disease (MRD) monitoring by next-generation sequencing before allogeneic hematopoietic cell transplantation in AML (2021) (1)
Generation and characterization of a novel hematopoietic progenitor cell line with DC differentiation potential (2006) (1)
Molecular Characterization of the Translocation (10;11)(p13;q14): MLLandCALMare Fused toAF10in Morphologically Different Subsets of Acute Leukemia (2001) (1)
Identification of a Cryptic Insertion ins(11;X)(q23;q28q12) Resulting in a KMT2A-FLNA Fusion in a 13-Month-Old Child with Acute Myelomonocytic Leukemia (2017) (1)
In Acute Myeloid Leukemia with Complex Karyotype TP53 Alterations Are Associated with Specific Genomic Aberrations and Predict Inferior Survival. (2009) (1)
Assessment of Clonal Evolution in 42 AML with NPM1 Mutations by Molecular Characterization of Paired Diagnosis and Relapse Samples (2011) (1)
Impact of PPM1D mutations in patients with myelodysplastic syndrome and deletion of chromosome 5q (2021) (1)
Constitutional SAMD9L Mutations Cause Familial Myelodisplastic Syndrome with Monosomy 7 and Stable Revertant Mosaicism (2017) (1)
Casein Kinase 1A1 (CSNK1A1) Is Recurrently Mutated in MDS Patients with Deletion of Chromosome 5q (2014) (1)
In vitro ciliary development in an epithelial stem equivalent cell line M3E3/C3 derived from the fetal Syrian hamster lung (2014) (1)
Recurrent 6pLOH Is the Most Common Somatic Lesion in Refractory Cytopenia of Childhood and Occurs Very Infrequently in Severe Aplastic Anemia (2012) (1)
Prevalence Rates of Pathogenic Mutations in theBRCA1andBRCA2Genes in Families with Different Disease Histories: Results from the German Consortium for Hereditary Breast and Ovarian Cancer. (2009) (1)
response in childhood acute lymphoblastic leukemia Distinct gene expression profiles determine molecular treatment (2004) (1)
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with a Related Donor in Chronic Myeloid Leukemia (CML): An Explanation for Fast Improvement of Survival in Two Consecutive German CML Studies. (2009) (1)
Cytogenetic subtyping of diffuse large B-cell lymphomas (2001) (1)
BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone. (2021) (1)
Short Telomeres Before Lenalidomide Treatment Predict Leukemic Progression In Patients with Myelodysplastic Syndrome and Deletion 5q (2010) (1)
The knockout of the HMG-Box domain of the porcine SRY-gene by CRISPR/Cas RNP microinjection causes sex reversal in gene-edited pigs (2020) (1)
221 Occurrence of trisomy 8 (+8) in patients with Low- or Int-1-risk MDS with deletion 5q [del(5q)] treated with lenalidomide (2011) (1)
Lenalidomide reexposure After Short Interruption In Del(5q) MDS Patients at Relapse of Transfusion Dependence (2010) (1)
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history (2018) (1)
Proteasome Inhibitor Bortezomib Induces Apoptosis in Prednisone-Resistant Childhood Acute Lymphoblastic Leukemia Cells. (2009) (1)
Discontinuation of Lenalidomide in Patients with Transfusion-Dependent Low- and Intermediate-1 Risk Myelodysplastic Syndromes with Del(5q): Sustained Remissions, but Not Cure. (2009) (1)
Kappa- and lambda-positive cells in centroblastic-centrocytic lymphoma (follicular lymphoma) may share a secondary chromosome aberration: reflections on early lymphoma development. (1995) (1)
Clinical Heterogeneity in RUNX1-Associated Familial Myelodysplastic Syndrome - Report of Two Novel Pedigrees with Childhoodleukemia (2016) (1)
The Association of Mutations in RUNX1 and CSF3R with the Development of Leukemia in Severe Congenital Neutropenia: A unique pathway in leukemogenesis (2013) (1)
Prognostic Factors in Adult Patients up to 60 Years with AML and Translocations of Chromosome 11q23: Individual Patient Data Based Analysis of the German AML-Intergroup. (2007) (1)
The Role of PPM1D Mutations in Lenalidomide Resistance and Progression in Patients with MDS and Deletion of Chromosome 5q (2018) (1)
Psychological Distress and Coping Ability of Women at High Risk of Hereditary Breast and Ovarian Cancer before Undergoing Genetic Counseling—An Exploratory Study from Germany (2021) (1)
Establishment and Characterization of a Pair of Patient-derived Human Non-small Cell Lung Cancer Cell Lines from a Primary Tumor and Corresponding Lymph Node Metastasis. (2016) (1)
Impact of Variant t(9;22) and Additional Cytogenetic Aberrations at Diagnosis on Prognosis of CML (2010) (1)
Clonal Heterogeneity in the 5q- Syndrome: NPMc+ and p53 Expressing Progenitors Are Insensitive to Lenalidomide Treatment and Expand at Disease Progression (2008) (1)
Equivalence of BCR-ABL Transcript Levels <1% According to the International Scale with Complete Cytogenetic Response in Chronic Phase CML Patients. (2012) (1)
296 Telomere shortening is associated with AML progression in patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide (2011) (1)
269 Mechanisms of action of lenalidomide on erythroblastic islands in patients with low- or intermediate-1-risk MDS with del(5q) chromosome abnormality (2011) (1)
Octasomy 21 in a patient with secondary AML after CMML: the role of acquired NRAS mutations in triggering aneuploidy (2018) (1)
In memoriam: Prof. Dr. rer. nat. Dr. med. h.c. Lore Zech; 24.9.1923 – 13.3.2013: Honorary member of the European Society of Human Genetics, Honorary member of the German Society of Human Genetics, Doctor laureate, the University of Kiel, Germany (2013) (0)
Favorable Prognostic Impact of WT1 SNP rs16754 in Cytogenetically Normal AML Independent of MN1, BAALC, and ERG Expression. (2009) (0)
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity (2018) (0)
Subject Index, Vol. 70, 1995 (1995) (0)
Development of a Data Portal for Aggregation and Analysis of Genomics Data in Familial Platelet Disorder with Predisposition to Myeloid Malignancy - the RUNX1.DB (2018) (0)
Correction to: Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies (2022) (0)
Hereditary Ovarian Carcinoma (2020) (0)
The impact of breast cancer morphology on the prediction of a BRCA1 mutation (2008) (0)
European standard clinical practice - Key issues for the medical care of individuals with familial leukemia. (2023) (0)
Next Generation Sequencing for Minimal Residual Disease Monitoring in AML Patients with FLT3-ITD, (2011) (0)
Mutations in the Gene of Neutrophil Elastase Associated with Congenital Neutropenia Lead to Alteration of Intracellular Trafficking and Proteolytic Function of NE Protein. (2004) (0)
in 2853 adult patients with newly diagnosed AML The impact of therapy-related acute myeloid leukemia (AML) on outcome (2011) (0)
Acknowledgement of Reviewers (2000) (0)
The Pattern Of Cytogenetic Aberrations In CML BC Stratified For Treatment (2013) (0)
Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomas. (2023) (0)
Can Bortezomib Treatment Overcome Glucocorticoid Resistance of Childhood Acute Lymphoblastic Leukemia Cells (2007) (0)
Acknowledgement of Reviewers (2000) (0)
Dynamic Telomere Shortening and Chromosomal Instability in Irradiated CD34+ Cells Transduced with TP53 Hotspot Mutations R175H, R248W and R249S (2015) (0)
Unbalanced Translocation t(5;17) Resulting In a TP53 Loss As Recurrent Aberration In Myelodysplastic Syndrome With Complex Karyotype (2013) (0)
MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF (2022) (0)
A STUDY ON THE CLINICAL SIGNIFICANCE OF THE WHO AML SUBTYPE INV(3)(Q21Q26.2)/T(3;3)(Q21;Q26.2) AND VARIOUS OTHER 3Q CHROMOSOMAL ABNORMALITIES IN 6,819 AML CASES (2010) (0)
Decisions Taken in Children and Adolescents with Chronic Myeloid Leukemia (CML) at Failure of Imatinib Treatment (2014) (0)
Unsupervised Analysis of Human Leukemia Cells Identifies the Valosin-Containing Protein as a Putative Marker for Glucocorticoid Resistance. (2004) (0)
O-003 ASXL1 frameshift mutations in patients with MDS and AML following MDS after allogeneic SCT: Update on 206 patients (2013) (0)
Deregulation of the endogenous C/EBPβ LIP isoform predisposes to tumorigenesis (2014) (0)
Subject Index Vol. 6, 2003 (2004) (0)
Effect of cytogenetics at diagnosis on outcome of CML: Results from the randomized German CML Study IV. (2011) (0)
566 FLUORESCENCE IN SITU HYBRIDIZATION (FISH) ANALYSIS FOR THE DIAGNOSIS OF HCC (2010) (0)
Subject Index Vol. 6, 2003 (2004) (0)
lymphoma loci in classical Hodgkin BCL11A and REL Recurrent involvement of the (2011) (0)
Telomere Attrition and Chromosomal Instability During Long-Term Cultivation of Hematopoietic Stem Cells, (2011) (0)
Genetics in inborn errors of immunity: pediatric autoinflammatory phenotypes and the underlying genetic causes in 125 families (2022) (0)
P-252 Routes of clonal evolution into complex karyotypes in myelodysplastic syndrome patients with del(5q) (2013) (0)
Prevalence and Clinical Impact of Additional Cytogenetic Abnormalities in Patients (Pts) with Myelodysplastic Syndromes (MDS) and Deletion 5q from the MDS-003 and MDS-004 Studies (2014) (0)
Prognostic Impact of BAALC Expression in the Context of Other Molecular Markers in Cytogenetically Normal Acute Myeloid Leukemia. (2007) (0)
Recurrent fusion of PCM1 to JAK2 in atypical chronic myeloid leukemia and acute leukemia associated with the t(8;9)(p21-22;p23-24) (2004) (0)
Contents Vol. 112, 2006 (2006) (0)
Sustained response to bevacizumab in a patient with mosaic neurofibromatosis type 2 carrying the NF2:c.784C>T p.(Arg262*) variant. (2022) (0)
Treatment-Related Hematologic Disorders All Patients With the T(11; 16)(q23; p13.3) That Involves MLL and CBP Have (2013) (0)
Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker (2023) (0)
Contents Vol. 73, 2006 (2007) (0)
PPM1D Mutations in MDS Patients with Deletion of Chromosome 5q (2017) (0)
Gain of Chromosome 21 Is Associated with Early Treatment Sensitivity in Childhood Acute Lymphoblastic Leukemia. (2005) (0)
and microarray analyses for experimental IBD identified by combining QTL : three major candidate genes (2015) (0)
Numerical Aberrations Involving The X Chromosome As a New Recurrent Aberration In Patients With Chronic Lymphocytic Leukemia (2013) (0)
Gene therapy for chronic granulomatous disease: Ups and downs (2009) (0)
[Clinical significance and molecular principles of chromosome aberrations in malignant lymphoma]. (1991) (0)
Cytomorphology and Clinical Outcome in 80 Patients with AML M4Eo and Inversion 16 (1997) (0)
Protein patterns in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an analysis using proteomics (2005) (0)
More Than One Mutation Is Required for Leukemia Development Following Retroviral Vector-Mediated Gene Transfer. (2004) (0)
Career satisfaction of German human genetics residents (2021) (0)
68 ASXL1 is frequently mutated and associated with a negative prognosis in MDS (2011) (0)
NEW FRONTIERS OF MYELOID NEOPLASIAS (2013) (0)
Molecular Aberrations in 107 Children with Myelodysplastic Syndrome (MDS). (2012) (0)
No mutations or methylation defects of the candidate tumor suppressor PDCD2 located at 6q27 can be detected in lymphoid neoplasms (2001) (0)
Deletions of Human Chromosome Region 6q23-24 in B-Lineage Neoplasias (1998) (0)
Subject Index Vol. 84, 1999 (1999) (0)
Characteristics and Prognosis of AML Patients with or without a History of Clonal Hematopoiesis (2015) (0)
[Cytogenetics of malignant lymphomas]. (1992) (0)
Gain of the Centromeric Region of Chromosome 8, a New Germline Alteration In Juvenile Myelomonocytic Leukemia (2010) (0)
Poor Prognosis in Children with ABL-Class Fusion Positive B-Cell Acute Lymphoblastic Leukemia Treated According to AIEOP-BFM Protocols (2019) (0)
Contents Vol. 6, 2003 (2004) (0)
Cytogenetic and molecular study of the PRDX4 gene in a translocation (X;18)(p22;q23) – a cautionary tale (2007) (0)
Cytogenetics in Pediatric MDS - Data of the EWOG-MDS 98 Study. (2005) (0)
Detection of Minimal Tumor Cell Populations by FICTION (1997) (0)
P-253 Unbalanced translocation t(5;17) resulting in a TP53 loss as recurrent aberration in myelodysplastic syndrome with complex karyotype (2013) (0)
DistinctMethylation Patterns of Benign andMalignant LiverTumors Revealed by QuantitativeMethylation Profiling (2005) (0)
Cytogenetic studies in congenital bone marrow failure syndromes (2006) (0)
Lentiviral Vector Induced Insertional Haploinsufficiency of Ebf1 Causes Leukemia in a Murine Bone Marrow Transplantation Model (2011) (0)
The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q) (2018) (0)
Lenalidomide Is Likely To Improve Overall Survival in Patients with del(5q) Myelodysplastic Syndrome with a Complex Karyotype. (2006) (0)
Leukemogenic Cascade Induced by a Constitutively Active Neurotrophin Receptor, ΔTrkA. (2006) (0)
Cytogenetically cryptic TNIP1-PDGFRB and PCM1-FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia (MLN-eo) in children (2021) (0)
Supplemental Human Genetics Point of View. (2019) (0)
Incidence and prognostic impact of cytogenetic aberrations in systemic mastocytosis (2016) (0)
Parallel deletion and duplication at 7q11.23 in a silent carrier for two reciprocal syndromic disorders. (2023) (0)
Biologic Determinants for AML Therapy (1998) (0)
Neurotrophin Receptors and Ligands Are Highly Expressed in Acute Leukemia and Promote Leukemogenesis. (2007) (0)
No Observation of Chromosomal Instability after Transplantation of RPS14- and TP53-Modified Human HSCs in NSG/NSGS Mice (2015) (0)
Analysis of WT1 Mutations and Combined Aberrations in Childhood Acute Myeloid Leukemia using Whole Exome Sequencing (2014) (0)
Genetic Counseling for Hereditary Tumors (2009) (0)
Fla-IDA Chemotherapy with or without Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia (2022) (0)
Evidence for Cooperation of Receptor Tyrosine Kinases and Activating NOTCH Mutations to Hyperactivate mTOR in T-Cell Leukemia: A Rationale Basis for Targeted Therapy (2011) (0)
Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence (2021) (0)
CML Study IV of CML: long-term observation of 1151 patients from the randomized Impact of additional cytogenetic aberrations at diagnosis on prognosis (2012) (0)
NF1 Alterations Are Common In AML with Complex Karyotype and Correlate with Specific Genomic Imbalances (2010) (0)
Treatment of Del(5q) Myelodysplastic Syndrome with All-Trans-Retinoic Acid and Tocopherol-α. (2004) (0)
Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes (2021) (0)
Mind the gap : translation of genetic research into clinical care in the context of RUNX1-associated leukaemia predisposition (2014) (0)
Functional characterization of RUNX1 variants in the context of FPDMM (2019) (0)
Short communication Detection of translocations involving the HOX11/TCL3 -locus in 10q24 by interphase fluorescence in situ hybridization (2001) (0)
Routes of Clonal Evolution Into Complex Karyotypes in Myelodysplastic Syndrome Patients with Del(5q) (2012) (0)
Receptor Tyrosine Kinases, Notch Mutations and PTEN Loss Converge On mTOR in T-ALL and Cause Addiction to Cap Dependent mRNA Translation. (2012) (0)
257 Inactivation of ICSBP by promoter methylation is likely involved in progressive leukemogenesis (2011) (0)
A third case of chronic eosinophilic leukemia with the (8;9)(p23;p24) translocation (2008) (0)
48 Gata2-Related Myelodysplastic Syndromes (Mds): Prevalence, Clinical Characteristics and Prognosis (2015) (0)
Inactivation of the Myc−Induced DNA Damage Response Promotes Lymphomagenesis and Treatment Resistance In Vivo. (2006) (0)
Characterization of Secondary Alterations in Mantle Cell Lymphomas Using Matrix-/Array CGH. (2004) (0)
Changes of the Niche of Erythropoiesis Appear to Contribute to Severe Transfusion-Dependent Anemia in a Significant Proportion of Patients with Myelodysplastic Syndromes (2015) (0)
Expression of the ETS Transcription Factor GABPα Is Correlated to BCR-ABL/ABL ratio in Human CML and Mediates Imatinib Sensitivity (2014) (0)
P115 Long-term transfusion independence in del(5q) patients despite discontinuation of lenalidomide (2009) (0)
Fish detection and characterization of IgA-mediated translocations in B-cell malignancies (1999) (0)
Mutations of the Spliceosome Complex Genes Occur In Adult Patients but Are Very Rare In Children with Myeloid Neoplasia (2011) (0)
TheBCL11gene family: involvement of BCL11Ain lymphoid malignancies (2001) (0)
Identification of Recurrent Submicroscopic Deletions of chromosome1q31.3 As Possible Molecular Prognostic Markers in Acute Promyelocytic Leukemia (APL) (2011) (0)
A Novel Alu Element Insertion in ATM Induces Exon Skipping in Suspected HBOC Patients (2023) (0)
31 Cytogenetics – for how much longer? (2011) (0)
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders (2021) (0)
Discontinuation of lenalidomide in patients with transfusion-dependent low- and intermediate-1 risk myelodysplastic syndromes with del(5q): sustained remissions, but not cure (2010) (0)
ID1 Expression Correlates with CEBPA Mutational Status and Is Not An Independent Risk Factor in Cytogenetically Normal AML (2011) (0)
Clinical Impact of TET2 Mutations in Acute Myeloid Leukemia Patients Harboring CEBPA Mutations: A Study of the AML Study Group (AMLSG) (2013) (0)
TRK-signaling, notch mutations and PTEN loss converge on mTOR in T-ALL and cause addiction to cap dependent mRNA translation (2013) (0)
Familial AML With Germline CEBPA Mutations: Extended Clinical Outcomes and Analysis Of Secondary Mutations Using Whole Exome Sequencing (2013) (0)
The Cytogenetic Profile In Lymphoid and Myeloid CML Blast Crisis (2013) (0)
150 INFLUENCE OF TP53 MUTATIONS ON HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIAS (AML) (2015) (0)
Subject Index Vol. 73, 2006 (2007) (0)
IDH Mutations Are Associated with an Increased Risk of Coronary Artery Disease and Cardiotoxicity in Patients with Established AML (2020) (0)
The Impact Of Balanced and Unbalanced Karyotypes On Prognosis Of CML: From Chronic Phase To Blast Crisis (2013) (0)
Various Other 3 q Abnormalities in Acute Myeloid Leukemia (2010) (0)
Recurrent DNMT3B Alterations Are Associated with Unfavorable Outcome in Dicentric (9;20)-Positive Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia (2022) (0)
Patient Derived Xenotransplantation Model of Atypical Chronic Myeloid Leukemia (aCML) (2015) (0)
Reduction of Erythropoiesis in MDS with 5q Deletion Is Associated with Aberrant SPARC and TNF-Alpha Gene Expression and Predicts the Efficacy of Lenalidomide Therapy. (2012) (0)
Short communication Amplification of ERBB2, RARA , and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia (2001) (0)
Significance of Copy Number Alterations for Molecular Treatment Response in Childhood Acute Lymphoblastic Leukemia. (2007) (0)
Impact Of The Proportion Of Metaphases With Isolated Del(5q) On Clinical Outcomes In Lenalidomide (LEN)-Treated Patients With IPSS Low-/Int-1-Risk Myelodysplastic Syndromes (MDS) In MDS-003 and MDS-004 (2013) (0)
ATRA resistance in AML patients MN1 overexpression induces acute myeloid leukemia in mice and predicts (2013) (0)
Correction: Generation and characterization of a novel hematopoietic progenitor cell line with DC differentiation potential (2021) (0)
PS1326 IMPLEMENTATION OF FUNCTIONAL ASSAYS TO CHARACTERIZE AND DETERMINE THE CLINICAL IMPACT OF RUNX1 VARIANTS OF UNCERTAIN SIGNIFICANCE IN SPORADIC DISEASES AS WELL AS IN THE CONTEXT OF FPDMM (2019) (0)
Erratum to Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo, [Cancer Cell, 25, 2014, 794-808] (2014) (0)
Two cancer‐predisposing variants in one family: Incidental finding of a fumarate hydrogenase (FH) germline variant in a family with Li–Fraumeni syndrome (2018) (0)
Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA (2015) (0)
Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases (2022) (0)
P-198 SPARC and TNF-α contribute significantly to erythroid failure in MDS with 5q deletion and influence considerably the efficacy of lenalidomide (2013) (0)
The Location of Genomic Breakpoints in AML1/RUNX1 and ETO in De Novo znd Therapy-Related Leukemia Patients sith T(8;21) Are Similar znd Colocalize with Topoisomerase II Cleavage Sites. (2004) (0)
Diverse Genetic Lesions In Myelodysplastic Syndromes Originate Exclusively In Rare MDS Stem Cells (2013) (0)
Prevalence and Impact on Outcomes of Additional Karyotypic Abnormalities in Patients (Pts) with Myelodysplastic Syndromes (MDS) and Del(5q) from the MDS-003 and MDS-004 Studies (2015) (0)
No evidence for breast cancer susceptibility associated with variants of BRD7, a component of p53 and BRCA1 pathways (2012) (0)
- mutated acute myeloid leukemia NPM 1 Clonal evolution in relapsed (2013) (0)
The Role of MSI2 Expression Levels on Outcome of MDS and AML Patients (2011) (0)
Rare and potentially fatal - Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in children. (2023) (0)
MN1 Expression Predicts Prognosis of Acute Myeloid Leukemia with Normal Cytogenetics. (2005) (0)
Drug-Response Signature Predicts Outcome in Adult Acute Myeloid Leukemia and Associates Poor Response with Molecular Characteristics of Hematopoietic Stem Cells. (2004) (0)
Telomere Shortening and Chromosomal Instability in Chronic Lymphocytic Leukemia (2011) (0)
Contents Vol. 114, 2006 (2006) (0)
Correction (2020) (0)
Abstract 509: Genomic profiling of acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link betweenATMmutations and chromothripsis (2017) (0)
Early treatment sensitivity in childhood acute lymphoblastic leukemia is associated with gain of chromosome 21. (2006) (0)
Systematic genetic analysis of pediatric patients with autoinflammatory diseases (2023) (0)
Treatment-Related AML Is An Independent Adverse Prognostic Factor for Relapse-Free and Overall Survival. An Analysis of 2,868 Adult Patients with Newly Diagnosed AML Enrolled On Seven AMLSG Treatment Trials. (2009) (0)
Hematologic Recovery from Venetoclax-Containing Regimens in Relapsed/Refractory Acute Myeloid Leukemia Patients Depending on Prior Allogeneic Hematopoietic Cell Transplantation (2019) (0)
ATIC, an enzyme involved in purine nucleotide biosynthesis anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive (2013) (0)
Consider family history. (2014) (0)
Emerging Marrow Fibrosis Is an Early Indicator of Imatinib Failure and Shortened Survival Time in CML Independent of Hematologic, Cytogenetic and Molecular Response. (2005) (0)
MicroRNA-449a Inhibits Triple Negative Breast Cancer by Disturbing DNA Repair and Chromatid Separation (2022) (0)
Hepatocyte telomere shortening of primary HCC correlates with increasing aneuploidy of chromosome 8 (2005) (0)
DETECTION OF TRISOMY 12 BYFLUORESCENCE INSITU HYBRIDIZATION IN B-CHRONIC LYMPHOCYTIC LEUKEMIA(B-CLL) (1995) (0)
Rapid and Reproducible Karyotyping with Nanopore Sequencing in AML Patients (2022) (0)
P305: COMPREHENSIVE TRANSCRIPTIONAL AND CYTOGENETIC PROFILING IMPROVES CLASSIFICATION AND DETECTION OF RISK-STRATIFYING MARKERS IN THE B-OTHER PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (2022) (0)
Coincidence of bcr/abl-Positive Chronic Myeloid Leukemia and bcr/abl-Negative Chronic Myeloproliferative Disorder and Its Relevance to the Course of Disease. (2007) (0)
Impact of unbalanced karyotypes at diagnosis on prognosis of CML. (2015) (0)
The Clinical and Prognostic Influence Of Mutations In The Cohesin Complex In Acute Myeloid Leukemia (2013) (0)
Homozygous frame shift variant in ATP7B exon 1 leads to bypass of nonsense-mediated mRNA decay and to a protein capable of copper export (2019) (0)
Frequency and prognostic value of dysmyelopoiesis in 114 patients with de novo acute myeloid leukemia (AML) in an ongoing study (1994) (0)
OnkoRiskNET: a multicenter, interdisciplinary, telemedicine-based model to improve care for patients with a genetic tumor risk syndrome (2022) (0)
Therapy-Related Myelodysplastic Syndrome Following Treatment for Childhood Acute Lymphoblastic Leukemia: Outcome of Patients Registered in the EWOG-MDS 98/06 Studies, (2011) (0)
Distinct gene expression proﬁles determine molecular treatment response in childhood acute lymphoblastic leukemia (2004) (0)
Functional characterization of a JAG1 5'UTR variant in a patient with clinically observed Alagille syndrome (2022) (0)
Assessment of Treatment Effects By Measurable Residual Disease Monitoring in NPM1-Mutated AML Patients Randomized for Gemtuzumab-Ozogamicin (GO) within the AMLSG 09-09 Trial of the German-Austrian AML Study Group (AMLSG) (2018) (0)
Reviewer ' s report Title : Tight correlation between expression of the Forkhead transcription factor FOXM 1 and HER 2 in human breast cancer (0)
Prognostic Value of Dysmyelopoiesis in 128 Patients with De Novo Acute Myeloid Leukemia (1997) (0)
A Complex Karyotype but Not Monosomy 7 Is an Independent Prognostic Factor in Advanced Childhood MDS. (2007) (0)
Students’ attitudes towards somatic genome editing versus genome editing of the germline using an example of familial leukemia (2021) (0)
Marrow Fibrosis in Myelodysplastic Syndromes - Its Significance in the Context of the WHO Classification of Disease and the International Prognostic Scoring System. (2004) (0)
Contents Vol. 6, 2003 (2004) (0)
Minimal Residual Disease (MRD) Monitoring in NPM1 Mutated Acute Myeloid Leukemia (AML): Impact of Concurrent FLT3-ITD and DNMT3A Mutations on MRD Kinetics and Clinical Outcome (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Brigitte Schlegelberger?

Brigitte Schlegelberger is affiliated with the following schools:

Institute of Cancer Research
University of Cologne
Kiel University
Hannover Medical School
University of Tübingen
University of Washington
Karolinska Institute
University of Southampton